Home > Young Investigators > Dutch Science at ERS

Dutch Science at ERS

Below is a list of Dutch scientists and where you can find them at the ERS! 

Sunday 28-September 2025

Presenter

Poster ID

Title

Session

Location

Time

Charlotte Born

526

Moving more: physical activity and lifestyle in chronic lung disease

PS-2

Board number: 13

08:00–09:30

Gimano Amatngalim

1298

A high-content airway epithelial and immune cell co-culture model of Th2 and Th17 inflammatory responses in asthma

112: Immunity in the airways: mechanisms and models in respiratory disease

(Location missing)

11:30–11:35

Merlijn Bonte

1278

Prevalence of structural lung abnormalities in a large pediatric bronchopulmonary dysplasia cohort

Oral presentation

Room 3A

11:40

Camiel Marijnissen

1390

Towards personalised dosing intervals of biologics in severe asthma: a Dutch nationwide survey on interval extensions

Asthma biologics: transitions, timing and treatment optimisation

Room PS-11, poster board 19

12:30–14:00

Camiel Marijnissen

1389

Real-world dosing interval extension of biologics in the Dutch severe asthma registry

Asthma biologics: transitions, timing and treatment optimisation

Room PS-11, poster board 18

12:30–14:00

Evelien Harms

 

Improving breathlessness diagnostics in primary care: the “Breathlessness Diagnostics in a Box” (BiaB) multi-country stepped-wedge RCT

178: primary care

Room Elicium 1

14:15–15:30

Evelien Harms

 

COPD management and optimisation opportunities in Dutch primary care using the COPDOptimiser

178: primary care

Room Elicium 1

14:15–15:30

Monday 30 September 2025

Presenter

Poster ID

Title

Session

Location

Time

Bente Brauwers

2650

impact of pulmonary rehabilitation on body composition in patients with COPD

227: 

PS-2

08:00–09:30

Taoyu Li

3181

 

253: Impact of environmental insults and inflammatory responses in COPD

PS7

08:00–09:30

Pranali Raut

 

Structural lung abnormalities in children and adults with cystic fibrosis after ETI using AI automated algorithms

Transformations in cystic fibrosis from structural lung changes to systemic implications of modulator therapy

 

10:00–10:45

Banchia Palmen

3416

Comparing Real-time Symptom Ratings Via Ecological Momentary Assessment and Traditional Questionnaires in Patients with COPD: Observational Study

288: Psychological and behavioural dimensions of respiratory innovation

Room 3A

11:00–12:15

Shahriyar Shahbazi Khamas

3799

Complementary asthma attacks predictors: Salivary microbiome, inflammatory mediators, and attacks history

316: Paediatric asthma: novel mechanistic and diagnostic insights

PS-24

12:30–14:00

Tuesday 1 October 2025

Presenter

Poster ID

Title

Session

Location

Time

Akash Gupta

5256

Contact-compression induces inflammatory and remodeling responses in bronchial epithelial cells

429: Advances in in vitro systems for understanding and treating pulmonary disease

PS 7

08:00–09:30

Bente Brauwers

4751

body composition in patients with COPD: the extremes.

403:

PS-2

08:00–09:30

Britt Dörssers

5190

Respiratory EMG and dyspnea during exercise in COPD patients

425: New insights: the physiology of airflow obstruction

PS-4

08:00–09:30

Daphne Peerlings

4681

Gut integrity and inflammation in COPD and exacerbations; the role of I-FABP

399: Clinical profile of COPD exacerbation

PS-16

08:00–09:30

Montse Janssen Bonás

5131

Effect of methotrexate and prednisone on intermediate monocytes in pulmonary sarcoidosis

 

PS-37, Board Number: 12

08:00–09:30

Sandra van Krimpen

5281

Myostatin signaling blockade impacts on muscle wasting in a mouse model of glucocorticoid-treated ECOPD

430: From cell to organ crosstalk in lung injury and repair

board number 6

08:00–09:30

Sandra van Krimpen

5284

The effects of nandrolone on muscle wasting in a mouse model of glucocorticoid-treated ECOPD

430: From cell to organ crosstalk in lung injury and repair

board number 9

08:00–09:30

Shahriyar Shahbazi Khamas

5301

Exhaled breath-based clusters in children with post-COVID condition

431: Breath detectives: volatile organic compounds and other exhaled biomarkers for detection of lung diseases

PS-9

08:00–09:30

Sophie Neuen

5409

Long-term alterations in prematurity-related lung disease: insights from a preclinical ovine model.

447: Best of injury and repair: from development to disease

location 3B

09:50- 09:55

Sarah van den Berg

5886

Socioeconomic inequalities in severe asthma in the Netherlands: a geospatial analysis in a nationwide cohort

492: Paediatric severe asthma and clinical trials

(Location missing)

(Time missing)

 

Presenter

Poster ID

Title

Session

Location

Time

Irene Mommers

364

Real-world effectiveness of antibiotics in addition to oral corticosteroids for managing asthma exacerbations in adults

41: Airway disease exacerbations under the microscope

 

 

Esther I. Metting

2039

Culture matters: A cross-country comparison in COPD patients of technology acceptance

 

 

 

Sven Manse

3190

A novel perfused muscle-on-chip platform to study muscle impairments in COPD

 Ex vivo modelling in lung research: new frontiers

Board number: 7

 

Ali Dehghani

3739

OCCUTIONAL AND ENVIRONMENTAL CUASES OF ASTHMA

 

 

 

Sven Manse

5279

Inflammation diminishes muscle regeneration induced by mitochondrial impairment in COPD

From cell to organ crosstalk in lung injury and repair

Board number: 4